Clinical Data Units to Offer Affymetrix's New DMET Services | GenomeWeb
NEW YORK (GenomeWeb News) — Affymetrix today launched its Drug Metabolizing Enzymes and Transporters early-access service program and announced that two units of Clinical Data would provide the services worldwide.
 
Affymetrix is initially launching the pharmacogenomics DMET panel as a service, which also is available through its clinical lab service in South San Francisco. The firm has said that it intends to offer the DMET panel as a catalogue product this year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.